Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

280
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
280
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

288
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
288
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

211
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
211
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

519
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
519
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

855
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
855
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

938
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
938

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A study of the utilization profile of donor corneas with a death-to-retrieval time of more than twelve hours.

Indian journal of ophthalmology·2026
Same author

Integrating phenotypic traits, multivariate statistics, and machine-learning models to predict yield in Himalayan kiwifruit (Actinidia deliciosa) orchards.

Journal of the science of food and agriculture·2026
Same author

Effect of Preoperative Donor Hydration on Outcomes in Living Donor Renal Transplantation: A Prospective Randomised Study.

Journal of the West African College of Surgeons·2026
Same author

Exogenous application of bio-regulators and pinching operations on physiological efficacy, phenology, and productivity of bottle gourd (Lagenaria siceraria (Mol.) Standl).

BMC plant biology·2026
Same author

Delayed versus Early Umbilical Cord Clamping in Preterm Multiple Gestation: A Randomized Controlled Trial.

American journal of perinatology·2026
Same author

Comparative Evaluation of 10-0 Vicryl Sutures Versus 10-0 Nylon Sutures in Pediatric Cataract Surgery.

Journal of pediatric ophthalmology and strabismus·2026

Related Experiment Video

Updated: Jan 21, 2026

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.8K

Cannabis hyperemesis syndrome.

Umesh Sharma1

  • 1Community Division of Hospital Medicine, Mayo Clinic Health System, Rochester, Minnesota, USA.

BMJ Case Reports
|October 17, 2018
PubMed
Summary

Chronic cannabis use can lead to cyclical nausea and vomiting. Stopping cannabis use can resolve these symptoms, offering relief for patients with cannabinoid hyperemesis syndrome.

Area of Science:

  • Gastroenterology
  • Toxicology

Background:

  • Cannabis use is prevalent, and its adverse effects are increasingly recognized.
  • Cannabinoid hyperemesis syndrome (CHS) is a condition associated with chronic cannabis consumption.

Observation:

  • A young woman with a history of chronic cannabis use presented with acute, cyclical nausea, vomiting, and abdominal pain.
  • Her symptoms were severe and persistent, lasting for two days.
  • Standard clinical and laboratory evaluations ruled out other potential causes for her gastrointestinal distress.

Findings:

  • The patient experienced significant symptom relief with topical capsaicin, hot showers, and antiemetic medications.
  • Her condition resolved, and she was discharged after a four-day hospital stay.
  • She was counseled on the adverse effects of cannabis and opted to cease use entirely.
Keywords:
drugs misuse (including addiction)global healthtoxicologyunwanted effects / adverse reactions

More Related Videos

Employing Aeroponic Systems for the Clonal Propagation of Cannabis
03:41

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

4.6K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

Related Experiment Videos

Last Updated: Jan 21, 2026

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.8K
Employing Aeroponic Systems for the Clonal Propagation of Cannabis
03:41

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

4.6K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

Implications:

  • This case highlights the importance of considering cannabinoid hyperemesis syndrome in patients with unexplained cyclical vomiting.
  • Discontinuation of cannabis is the primary treatment for CHS.
  • Patient education regarding the potential harms of chronic cannabis use is crucial for management and prevention.